Us Bancorp \De\ Brainstorm Cell Therapeutics Inc. Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$3.01 - $4.01 $9,030 - $12,030	-3,000 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$11.19 - $16.92 $5,595 - $8,460	500 Added 20.0%	3,000 $51,000
Q1 2020 May 13, 2020	BUY	$4.01 - $8.88 $8,922 - $19,758	2,225 Added 809.09%	2,500 $12,000
Q3 2017 Nov 13, 2017	BUY	$3.98 - $4.36 $1,094 - $1,199	275	275 $1,000

10.8M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $83.2M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.